Patent · US Active

Compositions for weight management

US7728015B2 · kind B2 · utility

1Cited by
2References
7Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 28, 2006
Grant dateJun 1, 2010
Priority date
Expiry dateJun 11, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P3/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutical compositions are disclosed comprising betahistine, or a salt thereof, and olanzapine in amounts effective to reduce the weight gain associated with olanzapine administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.